ZP-2307

N/A

Report date: 2025/01/15 20:00:32
NME

Base Information

Drug NameZP-2307
Drug Alias NameZP-2307
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionParathyroid hormone receptor agonists
TargetsParathyroid hormone receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesZealand Pharma A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZealand Pharma A/S
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A